| |
| |
|
| Insider
Information: |
Haqq Christopher |
| Relationship: |
|
| City: |
Brisbane |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
333,924 |
|
|
Indirect Shares
|
20,000 |
|
|
| Direct
Value |
$237,287 |
|
|
|
Indirect Value
|
$13,996 |
|
|
| Total
Shares |
353,924 |
|
|
| Total
Value |
$251,283 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Atara Biotherapeutics, Inc. |
ATRA |
EVP, R&D & Chief Scien... |
2019-02-15 |
271,943 |
2019-02-15 |
20,000 |
Premium* |
|
|
Surrozen Ord Shs |
SRZN |
Former Director |
2021-08-11 |
30,000 |
2021-08-11 |
0 |
Premium* |
|
|
Elicio Therapeutics Ord Shs |
ELTX |
|
2023-06-01 |
31,981 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
59 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 3 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ATRA |
Atara Biotherapeutics, In... |
EVP, R&D & Chief Scientific Of |
• – – |
2017-05-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
829 |
381,684 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Medical Officer |
• – – |
2016-11-15 |
4 |
AS |
$19.95 |
$32,000 |
D/D |
(1,604) |
383,173 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Medical Officer |
• – – |
2016-09-22 |
4 |
A |
$0.00 |
$0 |
D/D |
90,000 |
383,948 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Medical Officer |
• – – |
2016-11-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
829 |
384,777 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
EVP, R&D & Chief Scientific Of |
• – – |
2017-03-15 |
4 |
AS |
$19.60 |
$117,600 |
D/D |
(6,000) |
386,855 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
EVP, R&D & Chief Scientific Of |
• – – |
2017-02-15 |
4 |
AS |
$15.49 |
$117,786 |
D/D |
(7,604) |
392,855 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
EVP, R&D & Chief Scientific Of |
• – – |
2017-02-09 |
4 |
AS |
$15.46 |
$216,054 |
D/D |
(13,975) |
399,630 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
EVP, R&D & Chief Scientific Of |
• – – |
2017-02-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
829 |
400,459 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
EVP, R&D & Chief Scientific Of |
• – – |
2017-02-06 |
4 |
A |
$0.00 |
$0 |
D/D |
49,500 |
413,605 |
0 |
- |
|
59 Records found
|
|
Page 3 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
